Michael G. K. Jones

The application of in vitro cell-free conversion systems to human prion diseases

J. Ironside, M. Head, A. Peden, 2010, Acta Neuropathologica.

Purification of normal cellular prion protein from human platelets and the formation of a high molecular weight prion protein complex following platelet activation.

I. Macgregor, M. Head, D. Pepper, 2005, Biochemical and biophysical research communications.

Effects of human PrPSc type and PRNP genotype in an in-vitro conversion assay

C. Prowse, M. Turner, J. Ironside, 2008, Neuroreport.

Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrPSc) associated with variant Creutzfeldt‐Jakob disease

C. Prowse, M. Turner, J. Ironside, 2008, Transfusion.

Influence of Intracerebral Hemorrhage Location on Incidence, Characteristics, and Outcome: Population-Based Study

C. Sudlow, P. Sandercock, G. Mead, 2015, Stroke.

Genotype-dependent Molecular Evolution of Sheep Bovine Spongiform Encephalopathy (BSE) Prions in Vitro Affects Their Zoonotic Potential*

J. Ironside, M. Head, M. Barria, 2014, The Journal of Biological Chemistry.

An Antibody to the Aggregated Synthetic Prion Protein Peptide (PrP106–126) Selectively Recognizes Disease‐Associated Prion Protein (PrPSc) from Human Brain Specimens

J. Ironside, I. Macgregor, D. Wight, 2009, Brain pathology.